Biographies

Faber’s clients benefit from Kori’s more than twenty years of experience in the pharmaceutical and biotechnology industries. She assists clients with contractual management for all types of clinical studies and works closely with both the client and clinical sites to ensure efficient contract review and negotiation.

Specifically, Kori assists clients with drafting and negotiating service, consulting and related agreements for preclinical development and clinical studies. She also helps clients prepare and manage agreements for US based and multi-national clinical trials, including CRO, vendor agreements and site clinical trial agreements.

Kori is the chair of Faber’s Black Civil Rights Education sub-committee as part of Faber’s commitment to equality, diversity and inclusion.

experience +

experience –

Albany Molecular Research, Inc. (AMRI) (now Curia Global, Inc.)

Contracts Manager

Responsible for agreements involving outsourced drug discovery and commercial manufacture of API
Worked with AMRI’s international subsidiaries on corporate governance and compliance
While a member of AMRI’s business development group, focused on proposal drafting and review, marketing and submissions for governmental contracts

Kori was previously employed at a bankruptcy law firm and as a field and laboratory supervisor on archaeological research projects in upstate New York and Central Mexico.

Kori completed doctorate level course work in Anthropology at the University at Albany, State University of New York, where she was awarded a graduate assistantship in research and teaching within the department.

Recent Client work +

RECeNT CLIENT WORK –

Multiple clinical trials sponsored by Deciphera Pharmaceuticals, LLC including multinational trials involving sites in North America, Europe, South America, Asia and Australia
A Phase 2 clinical trial sponsored by Syndax Pharmaceuticals, Inc. involving sites in the United States, Europe and Asia
A Phase 1 clinical trial sponsored by CG Pharmaceuticals, Inc. involving sites in the United States
Phase 1 clinical trials sponsored by Nurix Therapeutics, Inc. involving sites in the United States
A Phase 2 clinical trial sponsored by Sorrento Therapeutics, Inc. involving sites in the United States

Community +

Community –

Kori volunteers at Schultz’s Guest House, a 501c3 dog rescue shelter in Dedham, MA that rescues, rehabilitates and finds homes for homeless dogs. She is a member of the Drug Information Association and Model Agreement and Guidelines International.

Education

‍Brandeis University, B.A., cum laude

Kori

Kaufman

Associate Director, Contracts Specialist

Industry Experience